Austrian Patent Office Upholds Lipitor Patent
Pfizer Inc. has won yet another battle in its war against Ranbaxy Laboratories over its generic version of blockbuster cholesterol drug Lipitor, after the Austrian Patent Office upheld Pfizer's basic patent...To view the full article, register now.
Already a subscriber? Click here to view full article